David R. Hathaway, Chief Medical Officer at HeartWare International, Inc. (HTWR), sold 4,431 shares at $71.33 ($316K) on 2010-09-17, disclosed to the SEC on 2010-09-20.
Scheduled sale ($316k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HTWR | SELL | 2013-05-30 | $564K | — | Filing → |
| HTWR | SELL | 2013-05-22 | $2.8M | — | Filing → |
| HTWR | SELL | 2012-12-26 | $88K | — | Filing → |